These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18840152)
21. Considerations for planning and designing meta-analysis in oral medicine. Pinto A Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):194-202. PubMed ID: 23663987 [TBL] [Abstract][Full Text] [Related]
22. The ancient black art and transdisciplinary extent of pseudoreplication. Hurlbert SH J Comp Psychol; 2009 Nov; 123(4):434-43. PubMed ID: 19929111 [TBL] [Abstract][Full Text] [Related]
23. A systematic survey of the methods literature on the reporting quality and optimal methods of handling participants with missing outcome data for continuous outcomes in randomized controlled trials. Zhang Y; Alyass A; Vanniyasingam T; Sadeghirad B; Flórez ID; Pichika SC; Kennedy SA; Abdulkarimova U; Zhang Y; Iljon T; Morgano GP; Colunga Lozano LE; Aloweni FAB; Lopes LC; Yepes-Nuñez JJ; Fei Y; Wang L; Kahale LA; Meyre D; Akl EA; Thabane L; Guyatt GH J Clin Epidemiol; 2017 Aug; 88():67-80. PubMed ID: 28579378 [TBL] [Abstract][Full Text] [Related]
25. The ABC of non-inferiority margin setting from indirect comparisons. Julious SA Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354 [TBL] [Abstract][Full Text] [Related]
26. Missing data in rheumatologic studies and the practical reality of modern approaches to the analysis of incomplete subject data: comment on the article by Baron et al and the editorial by Boers. Steele R; Hudson M Arthritis Rheum; 2008 Sep; 59(9):1367-8. PubMed ID: 18759312 [No Abstract] [Full Text] [Related]
27. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Takemoto SK; Arns W; Bunnapradist S; Garrison LP; Guirado L; Kalo Z; Oniscu G; Opelz G; Scolari MP; Stefoni S; Yaqoob M; Brennan DC Transplantation; 2008 Jul; 86(1):18-25. PubMed ID: 18622271 [TBL] [Abstract][Full Text] [Related]
28. Consequences of handling missing data for treatment response in osteoarthritis: a simulation study. Olsen IC; Kvien TK; Uhlig T Osteoarthritis Cartilage; 2012 Aug; 20(8):822-8. PubMed ID: 22441031 [TBL] [Abstract][Full Text] [Related]
29. Introduction to observational studies: part 2. Pandis N Am J Orthod Dentofacial Orthop; 2014 Feb; 145(2):268-9. PubMed ID: 24485743 [No Abstract] [Full Text] [Related]
30. Assessing risk of bias in randomized controlled trials. Purgato M; Barbui C; Cipriani A Epidemiol Psichiatr Soc; 2010; 19(4):296-7. PubMed ID: 21322502 [TBL] [Abstract][Full Text] [Related]
31. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Heres S; Davis J; Maino K; Jetzinger E; Kissling W; Leucht S Am J Psychiatry; 2006 Feb; 163(2):185-94. PubMed ID: 16449469 [TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trials of antihypertensive drugs: all that glitters is not gold. McAlister FA; Straus S; Sackett D CMAJ; 1998 Sep; 159(5):488-90. PubMed ID: 9757173 [No Abstract] [Full Text] [Related]
33. Comparing antipsychotic efficacy. Tandon R Am J Psychiatry; 2006 Sep; 163(9):1645. PubMed ID: 16946199 [No Abstract] [Full Text] [Related]
34. The uncertainty principle and industry-sponsored research. Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436 [TBL] [Abstract][Full Text] [Related]
35. Sample size determination and statistical power in randomized controlled trials. Sjögren P; Hedström L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528 [No Abstract] [Full Text] [Related]
36. An analysis of methodologies that can be used to validate if a perioperative surgical home improves the patient-centeredness, evidence-based practice, quality, safety, and value of patient care. Vetter TR; Ivankova NV; Goeddel LA; McGwin G; Pittet JF; Anesthesiology; 2013 Dec; 119(6):1261-74. PubMed ID: 24005578 [TBL] [Abstract][Full Text] [Related]
37. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. Hannan EL JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302 [TBL] [Abstract][Full Text] [Related]
38. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates. Salim A; Mackinnon A; Christensen H; Griffiths K Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673 [TBL] [Abstract][Full Text] [Related]
39. Clinical recommendations of Cochrane reviews in three different fields of pediatrics (neonatology, neuropediatrics, and complementary and alternative medicine): a systematic analysis. Meyer S; Schroeder N; Willhelm C; Gortner L; Girisch W Pediatr Int; 2013 Jun; 55(3):396-8. PubMed ID: 23566199 [No Abstract] [Full Text] [Related]
40. From randomized trials to registry studies: translating data into clinical information. Brown ML; Gersh BJ; Holmes DR; Bailey KR; Sundt TM Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):613-20. PubMed ID: 18679381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]